| Literature DB >> 23113103 |
Th Tung1, Wh Chiu, Th Lin, Hc Shih, Ct Hsu.
Abstract
BACKGROUND: The purpose of this study was to explore any gender-related differences in prevalence of and condition-associated factors related to non-alcoholic fatty liver disease (NAFLD) amongst police population in Taipei, Taiwan.Entities:
Keywords: Gender Difference; Nonalcoholic fatty liver disease; Police Service; Prevalence
Year: 2011 PMID: 23113103 PMCID: PMC3481735
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
The gender and age specific prevalence of NAFLD among police screened subjects (n=1016)
| 20–29 | 220 | 58 | 26.6 | |
| 30–39 | 463 | 263 | 56.2 | <0.001 |
| ≧40 | 286 | 200 | 69.3 | |
| Total | 972 | 521 | 53.6 | |
| 20–29 | 16 | 2 | 12.5 | |
| 30–39 | 10 | 2 | 20.0 | 0.54 |
| ≧40 | 18 | 5 | 27.8 | |
| Total | 44 | 9 | 20.5 | |
| 20–29 | 236 | 60 | 25.4 | |
| 30–39 | 473 | 265 | 56.0 | <0.001 |
| ≧40 | 307 | 205 | 66.8 | |
| Total | 1016 | 530 | 52.2 |
Comparisons of characteristics of NAFLD among police screened subjects
| Age(yr) | 33.38±7.64 | 37.75±6.76 | 35.66±7.52 | <0.001 |
| SBP(mmHg) | 121.74±6.76 | 126.37±14.32 | 124.16±13.65 | <0.001 |
| DBP(mmHg) | 75.25±9.66 | 80.88±11.48 | 78.19±11.01 | <0.001 |
| BMI(Kg/m2) | 22.97±2.73 | 26.52±3.34 | 24.82±3.54 | <0.001 |
| Uric acid(mg/dl) | 6.56±1.34 | 7.14±1.41 | 6.86±1.41 | <0.001 |
| AST(U/L) | 20.06±6.46 | 25.60±14.51 | 22.95±11.73 | <0.001 |
| ALT(U/L) | 22.80±13.58 | 39.57±30.34 | 31.55±25.26 | <0.001 |
| Total cholesterol (mg/dl) | 185.37±32.97 | 203.37±39.00 | 194.76±37.33 | <0.001 |
| Triglyceride (mg/dl) | 114.87±136.95 | 190.80±194.01 | 154.48±173.26 | <0.001 |
| Fasting plasma glucose (mg/dl) | 87.42±13.15 | 92.10±22.27 | 89.86±18.62 | <0.001 |
Comparisons of characteristics of NAFLD stratified by gender among police screened subjects
|
| ||||||
|---|---|---|---|---|---|---|
| Age(year) | 33.24±7.47 | 37.74±6.73 | <0.001 | 35.11±9.54 | 38.22±8.60 | 0.38 |
| SBP(mmHg) | 122.94±11.82 | 126.59±14.29 | <0.001 | 106.34±10.12 | 113.78±10.52 | 0.06 |
| DBP(mmHg) | 76.00±9.45 | 81.03±11.48 | <0.001 | 65.54±6.56 | 72.22±7.14 | 0.01 |
| BMI(kg/m2) | 23.10±2.67 | 26.56±3.33 | <0.001 | 21.20±2.93 | 24.20±2.62 | 0.01 |
| Uric acid(mg/dl) | 6.71±1.24 | 7.17±1.39 | <0.001 | 4.67±1.07 | 5.26±1.42 | 0.18 |
| AST (mg/dl) | 20.31±6.56 | 25.77±14.58 | <0.001 | 16.74±3.74 | 15.78±2.68 | 0.47 |
| ALT(mg/dl) | 23.55±13.72 | 39.95±30.45 | <0.001 | 13.11±5.86 | 17.11±4.70 | 0.07 |
| Total cholesterol (mg/dl) | 185.03±33.06 | 203.18±39.15 | <0.001 | 189.74±31.93 | 214.33±28.04 | 0.04 |
| Triglyceride (mg/dl) | 118.76±141.15 | 192.44±195.21 | <0.001 | 64.77±32.98 | 95.89±41.52 | 0.02 |
| Fasting plasma glucose (mg/dl) | 87.55±13.61 | 92.18±22.45 | <0.001 | 85.77±3.51 | 87.22±1.86 | 0.24 |
Crude and adjusted odds ratio of associated factors for NAFLD among police screened subjects
| Gender | female | 9 | 35 | 0.22 (0.11–0.47) | --- |
| male | 521 | 451 | --- | ||
| Age (yr) | 20–29 | 60 | 176 | 1.00 | --- |
| 30–39 | 265 | 208 | 3.74 (2.65–5.28) | --- | |
| ≥40 | 205 | 102 | 5.90 (4.04–8.60) | --- | |
| Hypertension | yes | 412 | 445 | 3.11 (2.13–4.54) | 2.37 (1.60–3.52) |
| no | 118 | 41 | |||
| Higher BMI | yes | 119 | 322 | 6.78 (5.14–8.95) | 5.85 (4.38–7.82) |
| no | 411 | 164 | |||
| Hyperuricemia | yes | 151 | 212 | 1.94 (1.50–2.52) | 2.01 (1.52–2.66) |
| no | 379 | 274 | |||
| Higher AST | yes | 487 | 480 | 7.06 (2.98–16.75) | 5.51 (2.29–13.29) |
| no | 43 | 6 | |||
| Higher ALT | yes | 363 | 445 | 4.99 (3.45–7.22) | 4.16 (2.84–6.09) |
| no | 167 | 41 | |||
| Hypercholesterolemia | yes | 258 | 331 | 2.25 (1.74–2.91) | 1.86 (1.42–2.44) |
| no | 272 | 155 | |||
| Hypertriglyceridemia | yes | 376 | 443 | 4.22 (2.93–6.08) | 3.15 (2.16–4.59) |
| no | 154 | 43 | |||
| Higher fasting plasma glucose | yes | 513 | 483 | 5.34 (1.55–18.32) | 3.77 (1.07–13.28) |
| no | 17 | 3 |
Aujestment for gender and age
Multiple logistic regression of associated factors for NAFLD among police screened subjects
|
|
|
| ||||
|---|---|---|---|---|---|---|
| Gender(male vs female) | --- | --- | --- | --- | 1.99 | 1.12–4.58 |
| Age(yrs) | 1.07 | 1.05–1.09 | 1.03 | 1.00–1.10 | 1.07 | 1.05–1.09 |
| Hypertension (yes vs no) | 1.24 | 0.79–1.93 | --- | --- | 1.24 | 0.79–1.94 |
| Higher BMI (yes vs no) | 4.39 | 3.23–5.98 | 1.10 | 1.01–6.05 | 4.41 | 3.25–5.97 |
| Hyperuricemia (yes vs no) | 1.35 | 1.07–1.86 | 3.45 | 0.63–18.97 | 1.40 | 1.02–1.91 |
| Higher AST (yes vs no) | 2.15 | 0.80–5.74 | --- | --- | 2.14 | 0.80–5.73 |
| Higher ALT(yes vs no) | 2.31 | 1.50–3.56 | --- | --- | 2.30 | 1.49–5.34 |
| Hypercholesterolemia (yes vs no) | 1.33 | 1.01–1.82 | 2.02 | 0.38–10.85 | 1.36 | 1.02–1.84 |
| Hypertriglyceridemia (yes vs no) | 1.55 | 1.01–2.37 | --- | --- | 1.54 | 1.01–2.36 |
| Higher fasting plasma glucose (yes vs no) | 2.01 | 0.48–8.39 | --- | --- | 2.05 | 0.49–8.57 |